Dyne Therapeutics Inc (DYN)

$14.13 -0.64 (-4.33%)
Market Cap 1.50B
Revenue (ttm) 0.00
Net Income (ttm) -235.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,476,100
Avg Vol 1,343,132
Day's Range N/A - N/A
Shares Out 101.77M
Stochastic %K 1%
Beta 1.16
Analysts Strong Sell
Price Target $50.83

Latest News on DYN

Why Is Neuromuscular-Focused Dyne Therapeutics Stock Trading Lower On Friday?

Jan 10, 2025, 1:40 PM EST - 7 days ago

Why Is Neuromuscular-Focused Dyne Therapeutics Stock Trading Lower On Friday?

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026

Jan 10, 2025, 6:30 AM EST - 7 days ago

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026

Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 7:30 AM EST - 8 days ago

Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

Jan 8, 2025, 4:05 PM EST - 9 days ago

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases

Nov 11, 2024, 6:15 PM EST - 2 months ago

Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases

Dyne Therapeutics to Present at Upcoming Investor Conferences

Nov 7, 2024, 4:15 PM EST - 2 months ago

Dyne Therapeutics to Present at Upcoming Investor Conferences

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations

Nov 4, 2024, 11:00 AM EST - 2 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Nov 3, 2024, 11:00 AM EST - 2 months ago

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations

Nov 2, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations

Dyne Therapeutics Inc Is Being Sued For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 31, 2024, 11:00 AM EDT - 2 months ago

Dyne Therapeutics Inc Is Being Sued For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Investors To Join A Case Against Dyne Therapeutics, Inc. For Securities Law Violations

Oct 30, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Encourages Investors To Join A Case Against Dyne Therapeutics, Inc. For Securities Law Violations

Dyne Therapeutics Inc May Have Committed Securities Fraud And Stockholders With Losses Are Urged To Reach Out To The Schall Law Firm

Oct 29, 2024, 11:00 AM EDT - 2 months ago

Dyne Therapeutics Inc May Have Committed Securities Fraud And Stockholders With Losses Are Urged To Reach Out To The Schall Law Firm

The Schall Law Firm Encourages Investors To Join An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Oct 27, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 26, 2024, 11:00 AM EDT - 2 months ago

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 20, 2024, 11:00 AM EDT - 3 months ago

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Impacted Shareholders Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Oct 19, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Securities Related Infractions

Oct 17, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Securities Related Infractions

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 16, 2024, 11:00 AM EDT - 3 months ago

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Urged To Help The Schall Law Firm

Oct 14, 2024, 11:00 AM EDT - 3 months ago

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Urged To Help The Schall Law Firm

Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases

Oct 9, 2024, 7:30 AM EDT - 3 months ago

Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases

The Schall Law Firm Invites Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Violating Securities Laws

Sep 29, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Invites Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Violating Securities Laws

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 3 months ago

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

The Schall Law Firm Urges Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Violating Securities Laws

Sep 27, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Urges Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Violating Securities Laws

Dyne Therapeutics Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Stockholders Are Invited To Reach Out

Sep 26, 2024, 11:00 AM EDT - 4 months ago

Dyne Therapeutics Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Stockholders Are Invited To Reach Out

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Violating Securities Laws And Impacted Investors Should Join The Inquiry

Sep 25, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Violating Securities Laws And Impacted Investors Should Join The Inquiry

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Stockholders With Losses Are Urged To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 4 months ago

Dyne Therapeutics Inc Is Being Investigated For Possible Securities Fraud And Stockholders With Losses Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Investors To Participate In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Sep 23, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Investors To Participate In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Dyne Therapeutics to Present at Chardan's 8th Annual Genetic Medicines Conference

Sep 23, 2024, 8:56 AM EDT - 4 months ago

Dyne Therapeutics to Present at Chardan's 8th Annual Genetic Medicines Conference

Shareholders Should Help The Schall Law Firm Investigate Whether Dyne Therapeutics Inc Committed Securities Fraud

Sep 22, 2024, 11:00 AM EDT - 4 months ago

Shareholders Should Help The Schall Law Firm Investigate Whether Dyne Therapeutics Inc Committed Securities Fraud

The Schall Law Firm Is Inquiring Into Dyne Therapeutics, Inc.'s Possible Securities Law Violations And Impacted Investors Are Urged To Lend A Hand

Sep 21, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Inquiring Into Dyne Therapeutics, Inc.'s Possible Securities Law Violations And Impacted Investors Are Urged To Lend A Hand

Dyne Therapeutics Inc May Have Engaged In Securities Fraud And The Schall Law Firm Wants Shareholders To Contribute To An Investigation

Sep 20, 2024, 11:00 AM EDT - 4 months ago

Dyne Therapeutics Inc May Have Engaged In Securities Fraud And The Schall Law Firm Wants Shareholders To Contribute To An Investigation

Investors Are Urged To Join The Schall Law Firm In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Sep 19, 2024, 11:00 AM EDT - 4 months ago

Investors Are Urged To Join The Schall Law Firm In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations

Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Shareholders to Inquire about Securities Investigation

Sep 19, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Shareholders to Inquire about Securities Investigation

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Wants Impacted Shareholders To Reach Out

Sep 18, 2024, 11:00 AM EDT - 4 months ago

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Wants Impacted Shareholders To Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dyne Therapeutics, Inc. (DYN) And Encourages Shareholders to Connect

Sep 18, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dyne Therapeutics, Inc. (DYN) And Encourages Shareholders to Connect

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Securities Related Infractions And Investors Are Invited To Join The Inquiry

Sep 17, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Securities Related Infractions And Investors Are Invited To Join The Inquiry

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dyne Therapeutics, Inc. (DYN) And Encourages Shareholders to Reach Out

Sep 17, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dyne Therapeutics, Inc. (DYN) And Encourages Shareholders to Reach Out

Shareholders Can Help The Schall Law Firm Investigate Dyne Therapeutics Inc For Possible Securities Fraud

Sep 16, 2024, 11:00 AM EDT - 4 months ago

Shareholders Can Help The Schall Law Firm Investigate Dyne Therapeutics Inc For Possible Securities Fraud

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc. (DYN) and Encourages Shareholders to Learn More About the Investigation

Sep 16, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc. (DYN) and Encourages Shareholders to Learn More About the Investigation

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Violating Securities Laws And The Firm Invites Investor Participation

Sep 15, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Violating Securities Laws And The Firm Invites Investor Participation

Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Stockholders to Inquire about Securities Investigation

Sep 15, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Stockholders to Inquire about Securities Investigation

An Investigation Has Been Launched Into Dyne Therapeutics Inc For Fraudulent Practices And Shareholders Can Assist The Schall Law Firm

Sep 14, 2024, 11:00 AM EDT - 4 months ago

An Investigation Has Been Launched Into Dyne Therapeutics Inc For Fraudulent Practices And Shareholders Can Assist The Schall Law Firm

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Possible Securities Law Violations And Impacted Investors Should Participate

Sep 13, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Possible Securities Law Violations And Impacted Investors Should Participate

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc. (DYN) and Encourages Investors to Learn More About the Investigation

Sep 13, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc. (DYN) and Encourages Investors to Learn More About the Investigation

Dyne Therapeutics Inc May Have Committed Securities Fraud And The Schall Law Firm Invites Stakeholders To Join An Inquiry

Sep 12, 2024, 11:00 AM EDT - 4 months ago

Dyne Therapeutics Inc May Have Committed Securities Fraud And The Schall Law Firm Invites Stakeholders To Join An Inquiry

Dyne Therapeutics, Inc.(DYN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Sep 12, 2024, 10:00 AM EDT - 4 months ago

Dyne Therapeutics, Inc.(DYN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation